![](https://investorshub.advfn.com/uicon/412550.png?cb=1597920802)
Tuesday, December 05, 2017 10:19:02 AM
In a deal that has the potential to reshape America's Healthcare Industry, CVS wants to be the entity that SELLS the drugs AND the insurer that PAYS for the drugs.
Now, sellers in a free enterprise system could not care less where the money (that pays for their product) comes from BUT when a seller offers to finance the transaction, there's a pretty-good chance the seller is confident they have an edge.
Diabetes cost the US $322,000,000,000 per year, or $1000 for each man, woman, and child in America. That number is 48% higher than it was in 2012!
Suppose an insurer had some way of regulating a drug treatment plan with more precision than the doctor, pharmacist, patient method in use today?
Just a thought!
Recent ALRTF News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/29/2023 12:53:49 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/28/2023 08:49:25 PM
FEATURED Element79 Gold Corp Appoints Warren Levy to Board of Directors • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM